Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.
about
White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosisMeta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociInflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosisEmerging therapies in multiple sclerosis.Regional MRI perfusion measures predict motor/executive function in patients with clinically isolated syndromeDown-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination.HLA B*44: protective effects in MS susceptibility and MRI outcome measures.Management of optic neuritis in Canada: survey of ophthalmologists and neurologists.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort.Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning.CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesQuantitative T2' imaging in patients with clinically isolated syndromeClinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and ManagementGlatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Structural Brain Network Characteristics Can Differentiate CIS from Early RRMSMultiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosisImpairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis.Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesSingle nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.A prospective cohort study of vitamin D in optic neuritis recovery.The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.Imaging in multiple sclerosis.Resting state networks change in clinically isolated syndrome.Coping and its importance for quality of life in patients with multiple sclerosis.White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome.Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?Acute disseminated encephalomyelitis that meets modified McDonald criteria for dissemination in space is associated with a high probability of conversion to multiple sclerosis in Taiwanese patients.Brain atrophy at onset and physical disability in multiple sclerosis.Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions.Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study.Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict early conversion into clinically definite multiple sclerosis.
P2860
Q24642079-D9A051CD-B142-4A79-BC52-C5A4F6A1A5C3Q24656799-A1F4798E-9B70-4E90-A96B-D3A5E113EF60Q28483194-79277F43-7872-4587-80BA-DD13CDF8AF5EQ31015100-25D6B053-AA19-4096-826F-7CD487EC64D9Q33552393-E29542BD-8184-42CD-A6DA-0568D894B11FQ33709707-285F76D9-1FFA-4B8D-B843-136EAAC6DF4EQ34099194-6129C990-D42C-41B6-A8E4-598286029204Q34369920-30509552-292D-4BDE-9759-6B0180E8A7F5Q34468304-A4B7AFF8-D895-4415-A906-36E2C7D66028Q34654987-986978A8-2A9E-4A5D-96D5-4B2E7485543FQ35137514-65CD75D7-CA0A-4F20-9561-BBC07BBB5113Q35571261-12C15718-807A-47C3-9183-09F5B8243EEFQ35980966-5DADF07D-8A60-423E-B9EA-62039DDF9909Q36329075-FD88EAFE-AD93-4889-ABDB-FBB33110428BQ36432500-EA40B989-3F2A-4591-9DE7-98F7B08D416CQ36527375-B59BC5C5-4E75-47B7-8388-B201611AE448Q36818197-BDD27BDB-9E49-4653-9C68-DABB88424854Q37316388-7EF6D5AB-53C8-4F84-A6CD-537B39074838Q37425118-A459F3CF-C27A-46C8-9E37-DCB71CE938BBQ37712459-7C8B2577-C8EA-47B0-A639-9E81EB9F58C1Q37990779-9F8B9040-8EF1-43EF-99E6-F8621A90138CQ39870622-7CFA2250-5038-4D9E-AABF-89BF0BE63313Q41065896-5E331DEA-CF9E-4562-8F9D-E6F7209BE149Q42087600-F837DD81-28E5-42C1-9D5A-5DF05B55C3DBQ43587438-6930FABB-1777-40A5-B65E-189EC2AAD2ECQ44412190-1FC19FC6-3C6D-47A2-B643-6805B2CC1932Q45324992-A8F8B445-7EC5-4E9B-89AB-7D088A2E9A31Q46043515-21157016-E267-4486-BBDF-B7329D626DA7Q48160123-54BB8E67-8B83-4203-91CE-4937811A8544Q48339336-1F44E5D8-EC64-441C-B855-6FE449F9A36AQ49083945-21B531B6-56D4-427C-845F-FF4B8C33D27EQ49089264-3472EDF0-85C3-4884-A4E5-FCFE6025C174Q49161827-EBB248D6-38C5-4499-B214-F5B9365D0D4FQ55518857-946681BA-CDCB-47B9-942A-323475321426
P2860
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinically isolated syndromes ...... ery processes, and management.
@ast
Clinically isolated syndromes ...... ery processes, and management.
@en
type
label
Clinically isolated syndromes ...... ery processes, and management.
@ast
Clinically isolated syndromes ...... ery processes, and management.
@en
prefLabel
Clinically isolated syndromes ...... ery processes, and management.
@ast
Clinically isolated syndromes ...... ery processes, and management.
@en
P2093
P1433
P1476
Clinically isolated syndromes ...... very processes, and management
@en
P2093
Alan Thompson
David Miller
Frederik Barkhof
P304
P356
10.1016/S1474-4422(05)70095-8
P577
2005-06-01T00:00:00Z